From bench to almost bedside: the long road to a licensed Ebola virus vaccine
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
From bench to almost bedside: the long road to a licensed Ebola virus vaccine
Authors
Keywords
-
Journal
EXPERT OPINION ON BIOLOGICAL THERAPY
Volume 18, Issue 2, Pages 159-173
Publisher
Informa UK Limited
Online
2017-11-17
DOI
10.1080/14712598.2018.1404572
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)
- (2017) Ana Maria Henao-Restrepo et al. LANCET
- Chimpanzee Adenovirus Vector Ebola Vaccine
- (2017) Julie E. Ledgerwood et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Recombinant Vesicular Stomatitis Virus Ebola Vaccine
- (2017) Jason A. Regules et al. NEW ENGLAND JOURNAL OF MEDICINE
- Implementation of an Ebola virus disease vaccine clinical trial during the Ebola epidemic in Liberia: Design, procedures, and challenges
- (2016) Stephen B Kennedy et al. Clinical Trials
- Safety and Immunogenicity of Novel Adenovirus Type 26– and Modified Vaccinia Ankara–Vectored Ebola Vaccines
- (2016) Iain D. Milligan et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- An Adenovirus Vaccine Expressing Ebola Virus Variant Makona Glycoprotein Is Efficacious in Guinea Pigs and Nonhuman Primates
- (2016) Shipo Wu et al. JOURNAL OF INFECTIOUS DISEASES
- Safety and immunogenicity of a chimpanzee adenovirus-vectored Ebola vaccine in healthy adults: a randomised, double-blind, placebo-controlled, dose-finding, phase 1/2a study
- (2016) Olga De Santis et al. LANCET INFECTIOUS DISEASES
- Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe
- (2016) Selidji T. Agnandji et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA
- (2016) Katie Ewer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Progression of Ebola Therapeutics During the 2014–2015 Outbreak
- (2016) Emelissa J. Mendoza et al. TRENDS IN MOLECULAR MEDICINE
- Cytomegalovirus-based vaccine expressing Ebola virus glycoprotein protects nonhuman primates from Ebola virus infection
- (2016) Andrea Marzi et al. Scientific Reports
- Selecting the Right Tool For the Job
- (2015) Arthur L. Caplan et al. AMERICAN JOURNAL OF BIOETHICS
- Immunology and evolvement of the adenovirus prime, MVA boost Ebola virus vaccine
- (2015) Yan Zhou et al. CURRENT OPINION IN IMMUNOLOGY
- Risk communication in times of crisis: Pitfalls and challenges in ensuring preparedness instead of hysterics
- (2015) G.-F. Bo l EMBO REPORTS
- As Ebola Epidemic Begins to Slow, Trials of Drugs and Vaccines Speed Up
- (2015) Bridget M. Kuehn JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Emergency Postexposure Vaccination With Vesicular Stomatitis Virus–Vectored Ebola Vaccine After Needlestick
- (2015) Lilin Lai et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Adenovirus-Vectored Vaccine Provides Postexposure Protection to Ebola Virus–Infected Nonhuman Primates
- (2015) Gary Wong et al. JOURNAL OF INFECTIOUS DISEASES
- Considerations in the Use of Nonhuman Primate Models of Ebola Virus and Marburg Virus Infection: Table 1.
- (2015) Thomas W. Geisbert et al. JOURNAL OF INFECTIOUS DISEASES
- Safety and immunogenicity of Ebola virus and Marburg virus glycoprotein DNA vaccines assessed separately and concomitantly in healthy Ugandan adults: a phase 1b, randomised, double-blind, placebo-controlled clinical trial
- (2015) Hannah Kibuuka et al. LANCET
- Ebola vaccine trials back on track
- (2015) Dara Mohammadi LANCET
- Safety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in China: preliminary report of a randomised, double-blind, placebo-controlled, phase 1 trial
- (2015) Feng-Cai Zhu et al. LANCET
- Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial
- (2015) Ana Maria Henao-Restrepo et al. LANCET
- Emergency Ebola response: a new approach to the rapid design and development of vaccines against emerging diseases
- (2015) Claire M Tully et al. LANCET INFECTIOUS DISEASES
- Single-dose attenuated Vesiculovax vaccines protect primates against Ebola Makona virus
- (2015) Chad E. Mire et al. NATURE
- High hopes for Guinean vaccine trial
- (2015) M. Enserink SCIENCE
- An Ebola whole-virus vaccine is protective in nonhuman primates
- (2015) A. Marzi et al. SCIENCE
- VSV-EBOV rapidly protects macaques against infection with the 2014/15 Ebola virus outbreak strain
- (2015) A. Marzi et al. SCIENCE
- A race for an Ebola vaccine: promises and obstacles
- (2015) Christopher L. Cooper et al. TRENDS IN MICROBIOLOGY
- Transmission of Ebola Viruses: What We Know and What We Do Not Know: Table 1
- (2015) Michael T. Osterholm et al. mBio
- The ring vaccination trial: a novel cluster randomised controlled trial design to evaluate vaccine efficacy and effectiveness during outbreaks, with special reference to Ebola
- (2015) BMJ-British Medical Journal
- Ebola vaccine to be tested on 30 000 volunteers
- (2015) A. Gulland BMJ-British Medical Journal
- The ring vaccination trial: a novel cluster randomised controlled trial design to evaluate vaccine efficacy and effectiveness during outbreaks, with special reference to Ebola
- (2015) BMJ-British Medical Journal
- Ebola vaccine to be tested on 30 000 volunteers
- (2015) A. Gulland BMJ-British Medical Journal
- Neurovirulence and Immunogenicity of Attenuated Recombinant Vesicular Stomatitis Viruses in Nonhuman Primates
- (2014) D. K. Clarke et al. JOURNAL OF VIROLOGY
- Safety and immunogenicity of a candidate tuberculosis vaccine MVA85A delivered by aerosol in BCG-vaccinated healthy adults: a phase 1, double-blind, randomised controlled trial
- (2014) Iman Satti et al. LANCET INFECTIOUS DISEASES
- Safety and immunogenicity of a modified-vaccinia-virus-Ankara-based influenza A H5N1 vaccine: a randomised, double-blind phase 1/2a clinical trial
- (2014) Joost H C M Kreijtz et al. LANCET INFECTIOUS DISEASES
- A Single Dose Respiratory Recombinant Adenovirus-Based Vaccine Provides Long-Term Protection for Non-Human Primates from Lethal Ebola Infection
- (2014) Jin Huk Choi et al. MOLECULAR PHARMACEUTICS
- Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp
- (2014) Xiangguo Qiu et al. NATURE
- Ebola experts seek to expand testing
- (2014) Declan Butler NATURE
- Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge
- (2014) Daphne A Stanley et al. NATURE MEDICINE
- Emergence of Zaire Ebola Virus Disease in Guinea
- (2014) Sylvain Baize et al. NEW ENGLAND JOURNAL OF MEDICINE
- Durability of a Vesicular Stomatitis Virus-Based Marburg Virus Vaccine in Nonhuman Primates
- (2014) Chad E. Mire et al. PLoS One
- Vaccinating captive chimpanzees to save wild chimpanzees
- (2014) K. L. Warfield et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immunization with vesicular stomatitis virus vaccine expressing the Ebola glycoprotein provides sustained long-term protection in rodents
- (2014) Gary Wong et al. VACCINE
- Venezuelan Equine Encephalitis Virus Replicon Particle Vaccine Protects Nonhuman Primates from Intramuscular and Aerosol Challenge with Ebolavirus
- (2013) A. S. Herbert et al. JOURNAL OF VIROLOGY
- Airway Delivery of an Adenovirus-Based Ebola Virus Vaccine Bypasses Existing Immunity to Homologous Adenovirus in Nonhuman Primates
- (2013) J. S. Richardson et al. JOURNAL OF VIROLOGY
- Antibodies are necessary for rVSV/ZEBOV-GP-mediated protection against lethal Ebola virus challenge in nonhuman primates
- (2013) A. Marzi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pathogenesis of Venezuelan equine encephalitis
- (2013) Katherine G. Taylor et al. VETERINARY MICROBIOLOGY
- Antibody Quality and Protection from Lethal Ebola Virus Challenge in Nonhuman Primates Immunized with Rabies Virus Based Bivalent Vaccine
- (2013) Joseph E. Blaney et al. PLoS Pathogens
- Animal models for Ebola and Marburg virus infections
- (2013) Eri Nakayama et al. Frontiers in Microbiology
- Nomenclature for Immune Correlates of Protection After Vaccination
- (2012) S. A. Plotkin et al. CLINICAL INFECTIOUS DISEASES
- A strategy to simultaneously eradicate the natural reservoirs of rabies and Ebola virus
- (2012) Gary Wong et al. Expert Review of Vaccines
- Cutaneous manifestations of filovirus infections
- (2012) Dieudonné Nkoghe et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Safety, Immunogenicity, and Surrogate Markers of Clinical Efficacy for Modified Vaccinia Ankara as a Smallpox Vaccine in HIV-Infected Subjects
- (2012) R. N. Greenberg et al. JOURNAL OF INFECTIOUS DISEASES
- Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010
- (2012) Rafael Lozano et al. LANCET
- Decreased Pre-existing Ad5 Capsid and Ad35 Neutralizing Antibodies Increase HIV-1 Infection Risk in the Step Trial Independent of Vaccination
- (2012) Cheng Cheng et al. PLoS One
- Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques
- (2012) G. G. Olinger et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Successful Treatment of Ebola Virus-Infected Cynomolgus Macaques with Monoclonal Antibodies
- (2012) X. Qiu et al. Science Translational Medicine
- Immune Parameters Correlate with Protection Against Ebola Virus Infection in Rodents and Nonhuman Primates
- (2012) G. Wong et al. Science Translational Medicine
- Eliminating Rabies in Estonia
- (2012) Florence Cliquet et al. PLoS Neglected Tropical Diseases
- Recombinant Vesicular Stomatitis Virus Vaccine Vectors Expressing Filovirus Glycoproteins Lack Neurovirulence in Nonhuman Primates
- (2012) Chad E. Mire et al. PLoS Neglected Tropical Diseases
- Management of Accidental Exposure to Ebola Virus in the Biosafety Level 4 Laboratory, Hamburg, Germany
- (2011) Stephan Günther et al. JOURNAL OF INFECTIOUS DISEASES
- Recombinant Adenovirus Serotype 26 (Ad26) and Ad35 Vaccine Vectors Bypass Immunity to Ad5 and Protect Nonhuman Primates against Ebolavirus Challenge
- (2011) T. W. Geisbert et al. JOURNAL OF VIROLOGY
- Mucosal parainfluenza virus-vectored vaccine against Ebola virus replicates in the respiratory tract of vector-immune monkeys and is immunogenic
- (2010) Alexander A. Bukreyev et al. VIROLOGY
- Replication-Deficient Ebolavirus as a Vaccine Candidate
- (2009) P. Halfmann et al. JOURNAL OF VIROLOGY
- Correlates of protective immunity for Ebola vaccines: implications for regulatory approval by the animal rule
- (2009) Nancy J. Sullivan et al. NATURE REVIEWS MICROBIOLOGY
- International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 neutralizing antibodies: Correlates of high Ad5 titers and implications for potential HIV vaccine trials
- (2009) T. Christopher Mast et al. VACCINE
- Vaccines: Correlates of Vaccine‐Induced Immunity
- (2008) Stanley A. Plotkin CLINICAL INFECTIOUS DISEASES
- Vesicular Stomatitis Virus-Based Ebola Vaccine Is Well-Tolerated and Protects Immunocompromised Nonhuman Primates
- (2008) Thomas W. Geisbert et al. PLoS Pathogens
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now